Published in Medical Letter on the CDC and FDA, September 6th, 2009
The EndyMed PRO implements the third generation 3DEEP™ radio frequency (RF) technology which uses multiple, phase controlled sources, and is the first product of this type to receive clearance to be marketed in the USA.
3DEEP™ uniquely controls the power, depth and 3-dimensional pattern of RF energy delivered to the skin. The 3DEEP technology results in minimal surface...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.